Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

BLOOD CELLS MOLECULES AND DISEASES

ACADEMIC PRESS INC

1. NCI NIH HHS [CA-84292-01, CA-0974823] Funding Source: Medline
2. NATIONAL CANCER INSTITUTE [U01CA084292] Funding Source: NIH RePORTER